Correction to: Stem Cell Research & Therapy (2020) 11:302 https://doi.org/10.1186/s13287-020-01788-3
Following the publication of this article [1], the authors notice the immunohistochemical staining of α-SMA in Fig. 2 contains incorrect images. The authors put the same picture in 2W (Sham Group) and 1W (P + M Group) by mistake when they assembled the figure. After checking the original data, the authors realized that there was an error with the image selection during manuscript preparation. In addition, the Fig. 2 legend also needs correction, that Fig. 2b is vWF staining, while Fig. 2c is SMA staining.
Changes of microenvironment and activation of Nrf2/HO-1 pathway in corpus cavernosum. A Masson’s trichrome staining was performed to assess the corporal fibrosis level in rat cavernous of all the three groups after different treatment (the area of smooth muscle is represented by red stain and the area of collagen by blue stain). B Representative immunohistochemical staining of vWF-positive smooth muscle (green) in Sham, DM, M, P + M Groups. C Representative immunohistochemical staining of α-SMA-positive smooth muscle (green) in Sham, DM, M, P + M Groups. D The expression of Nrf2 and HO-1 protein was observed at different time points among the groups.β-Actin was used as a loading control. E Effect of MSCs and/or probucol treatment on the ratio of smooth muscle to collagen in the corpus cavernosum in 2 weeks. Bars denote the mean densitometry ratio between smooth muscle content and collagen content per field. **p < 0.01 indicates significant difference compared with Sham Group. #p < 0.05 and ##p < 0.01 indicate significant difference compared with the DM Group
The correct Fig. 2 and the figure legend have been included in this correction.
The correction will not affect the result and scientific conclusion of the manuscript. The authors would like to apologize for any inconvenience caused.
Reference
Wang H, et al. Probucol enhances the therapeutic efficiency of mesenchymal stem cells in the treatment of erectile dysfunction in diabetic rats by prolonging their survival time via Nrf2 pathway. Stem Cell Res Ther. 2020;11:302. https://doi.org/10.1186/s13287-020-01788-3.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Wang, H., Zhang, K., Ruan, Z. et al. Correction to: Probucol enhances the therapeutic efficiency of mesenchymal stem cells in the treatment of erectile dysfunction in diabetic rats by prolonging their survival time via Nrf2 pathway. Stem Cell Res Ther 13, 47 (2022). https://doi.org/10.1186/s13287-022-02727-0
Published:
DOI: https://doi.org/10.1186/s13287-022-02727-0